Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients

1. Ocio, E.M.
2. Bringhen, S.
3. Martinez-Lopez, J.
4. San-Miguel, J.
5. Oliva, S.
6. Rodriguez-Otero, P.
7. Le Roux, N.
8. Dong, Y.
9. Doroumian, S.
10. Macé, S.
11. Mateos, M.-V.

Exportar

Exportar

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Exportar

×

Non se pode exportar o documento porque pertence a outro portal.

Texto completo

lock_openTexto completo externo

DOI: 10.1097/HS9.0000000000000829 GOOGLE SCHOLAR lock_openAcceso aberto editor

Obxectivos de Desenvolvemento Sustentable

• 

Fonte de datos: Scopus